← Leaderboards
Kebin Liu
Charlie Norwood Va Medical Center
$6,512,707
Attributed
$8,528,806
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,528,806 · 5
VA$0 · 3
By mechanism
R01$8,166,650 · 4
R21$362,156 · 1
I01$0 · 2
IS1$0 · 1
Top collaborators
- Yolonda L Colson5 shared
- Mark W Grinstaff5 shared
- Nicholas Hunter Oberlies5 shared
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoResistanceColorectal CancerNeoplastic CellMediatingColon CarcinomaTumorApoptosisMolecularCancer PatientSurvival RateCessation Of LifeBaseCellsCancer CellRegulationMalignant NeoplasmsHistone MethyltransferaseVerticillin ANeoplasm MetastasisGrowthDna MethylationProteinsGenetic Transcription
Grant awards (35)
Development of SUV39H1-selective inhibitor for human colon cancer therapy$488,240
R01 · FY2025 · CA · contact PI
Development of SUV39H1-selective inhibitor for human colon cancer therapy$494,269
R01 · FY2024 · CA · contact PI
Type I Interferon Regulation of Tumor Cell and Immune Cell Interaction in Human Colon Cancer$0
I01 · FY2024 · VA · contact PI
Type I Interferon Regulation of Tumor Cell and Immune Cell Interaction in Human Colon Cancer$0
I01 · FY2023 · VA · contact PI
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE$452,836
R01 · FY2022 · CA
Type I Interferon Regulation of PD-L1 Expression and Function in MDSCs$0
I01 · FY2022 · VA · contact PI
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE$610,821
R01 · FY2021 · CA
Type I Interferon Regulation of PD-L1 Expression and Function in MDSCs$0
I01 · FY2021 · VA · contact PI
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE$526,098
R01 · FY2020 · CA
Type I Interferon Regulation of PD-L1 Expression and Function in MDSCs$0
I01 · FY2020 · VA · contact PI
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE$489,515
R01 · FY2019 · CA
Role of IRF8 in Tumor Rejection and Suppression$298,566
R01 · FY2019 · CA · contact PI
Type I Interferon Regulation of PD-L1 Expression and Function in MDSCs$0
I01 · FY2019 · VA · contact PI
TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE$608,862
R01 · FY2018 · CA
Role of NF-kB in Fas-mediated Apoptosis and Tumor Suppression$315,400
R01 · FY2018 · CA · contact PI
Role of IRF8 in Tumor Rejection and Suppression$307,800
R01 · FY2018 · CA · contact PI
Role of NF-kB in Fas-mediated Apoptosis and Tumor Suppression$315,400
R01 · FY2017 · CA · contact PI
Role of IRF8 in Tumor Rejection and Suppression$307,800
R01 · FY2017 · CA · contact PI
ShEEP-IC: Request for Flow Cytometer$0
IS1 · FY2017 · VA · contact PI
Function of Verticillin A in Suppression of MDSC and CRC Stem Cells$0
I01 · FY2017 · VA · contact PI
Role of IRF8 in Tumor Rejection and Suppression$332,800
R01 · FY2016 · CA · contact PI
Role of NF-kB in Fas-mediated Apoptosis and Tumor Suppression$315,400
R01 · FY2016 · CA · contact PI
Function of Verticillin A in Suppression of MDSC and CRC Stem Cells$0
I01 · FY2016 · VA · contact PI
Role of NF-kB in Fas-mediated Apoptosis and Tumor Suppression$315,400
R01 · FY2015 · CA · contact PI
Role of IRF8 in Tumor Rejection and Suppression$307,800
R01 · FY2015 · CA · contact PI
H3K9 Methylation and Pancreatic Cancer Chemoresistance$165,209
R21 · FY2015 · CA · contact PI
Function of Verticillin A in Suppression of MDSC and CRC Stem Cells$0
I01 · FY2015 · VA · contact PI
Role of NF-kB in Fas-mediated Apoptosis and Tumor Suppression$313,498
R01 · FY2014 · CA · contact PI
H3K9 Methylation and Pancreatic Cancer Chemoresistance$196,947
R21 · FY2014 · CA · contact PI
Function of Verticillin A in Suppression of MDSC and CRC Stem Cells$0
I01 · FY2014 · VA · contact PI
Role of Epigenetic Repression of IRF8 in Tumor Progression/Metastasis$266,288
R01 · FY2012 · CA · contact PI
Role of Epigenetic Repression of IRF8 in Tumor Progression/Metastasis$266,288
R01 · FY2011 · CA · contact PI
Role of Epigenetic Repression of IRF8 in Tumor Progression/Metastasis$284,523
R01 · FY2010 · CA · contact PI
Role of Epigenetic Repression of IRF8 in Tumor Progression/Metastasis$274,523
R01 · FY2009 · CA · contact PI
Role of Epigenetic Repression of IRF8 in Tumor Progression/Metastasis$274,523
R01 · FY2008 · CA · contact PI